Remove Drug Development Remove Pharma R&D Remove Small Molecule Remove Trials
article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Unfortunately, it takes a decade or more to know whether your predictions in the drug discovery and development game were correct. The ways in which the financing framework for drug discovery and development works creates, in effect, a straightjacket that constrains and diminishes decision-making quality throughout the R&D process.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

Large pharma companies now spend more than $6 billion 4 on R&D per approved drug, compared to just $40 million 5 (in today’s dollars) in the 1950s, with approximately 85% of that spending coming after discovery. Take as an example patient recruitment, the most time-consuming part of a trial.